Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by Hechanova GroupEditha R Hechanova of Hechanova & Co, Inc discusses a patent infringement case regarding the importation and distribution of drugs used for hypertension -
Sponsored by Hong Kong Trade Development CouncilAlexander Ying, founder and CEO of AI fitness company DRESIO – and one of the winners of the IPHatch Hong Kong Competition 2019/20, discusses the key takeaways from his IPHatch experience
-
Sponsored by AJ ParkAJ Park describes the agreement in principle between New Zealand and the UK for the free trade agreement from an IP perspective
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Ajay Kumar of RNA Technology and IP Attorneys explore the key takeaways from guidelines introduced to establish fairness in claims and advertisements of food products
-
Sponsored by FB RiceBeata Khaidurova and James Coburn of FB Rice delve into a chronology of Australian Patent Office decisions and find a pattern of reasoning which shows that some UIs may be protectable under Australian patent law
-
Sponsored by Gün and PartnersZeynep Seda Alhas and Dilan Sıla Kayalıca of Gün and Partners consider the Turkish IP court’s ruling on an infringement case by Red Bull
